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Objectives: In vivo investigation of nitric oxide release in coronary bypass 
grafts has not been reported. We studied acetylcholine-induced nitric oxide 
release in viw) of coronary bypass grafts and vasomotor responses to 
acetylcholine ofgrafted coronary arteries in patients after coronary bypass 
grafting. Methods': We examined 24 internal thoracic artery grafts and 16 
saphenous vein grafts in 39 patients. The mean ages of the patients were 65 
years for the arterial grafts and 68 years for the venous grafts. Nitric oxide 
was measured as the plasma nitrite level by the Griess reaction. Before and 
after intragraft acetylcholine infusion (5 gtg), blood was sampled from the 
distal end of the graft, and angiograms were taken and analyzed by 
cine-densitometry. Results: The plasma nitrite concentration after stimula- 
tion with acetylcholine compared with the control value was 134% - 52% at 
4 minutes (p = 0.05) and 184% - 107% at 6 minutes (p = 0.01) in the 
arterial grafts; in the venous grafts these values were 101% - 24% at 4 
minutes (p = 0.96) and 108% - 36% at 6 minutes (p = 0.69). Low-dose 
acetylcholine dilated the coronary arteries supplied by arterial grafts by 
6.3% - 16.6% whereas coronary arteries supplied by venous grafts were 
reduced by 9.8% --- 11.8% in diameter and the vasoactive responses were 
different (p = 0.01). Conclusions: In vivo internal thoracic artery grafts had 
more endothelium-derived nitric oxide release in response to acetylcholine 
than did saphenous vein grafts after coronary bypass grafting. (J Thorac 
Cardiovasc Surg 1998;116:454-9) 
A rterial grafts, especially internal thoracic artery (ITA) grafts, recently have been used more often 
instead of saphenous vein grafts (SVGs) as the first 
choice for coronary artery revascularization] There 
are many reports that present he advantages of ITA 
grafts over venous grafts. First, ITA grafts have 
excellent patency and superior esistance to athero- 
sclerotic changes over the long-term postoperative 
period. 2 Second, they adapt physiologically to the 
flow demands of coronary circulation 3 and adapt 
anatomically to physical development in pediatric 
patients. 4 These advantages are derived mainly from 
the viability of the ITA grafts. 5 In organ bath 
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experiments, endothelial function in freshly har- 
vested ITAs and saphenous veins in the grafted or 
ungrafted state differed with respect o the release 
of nitric oxide (NO). 6-s In vivo investigation of NO 
release in implanted coronary bypass grafts, how- 
ever, has not yet been reported. The purpose of this 
study was to compare the acetylcholine-induced 
endothelial NO release in bypass grafts between 
ITAs and saphenous veins in patients after coronary 
artery bypass grafting and to evaluate the metabolic 
function of arterial and venous grafts. 
Patients and methods 
Patients. In 39 patients (36 men and 3 women), 40 
bypass grafts were studied during postoperative cardiac 
catheterization. Patients with any signs of ischemia, an- 
gina, heart failure, or stenosis of the bypass grafts were 
excluded from the study protocol. Patient profiles are 
shown in Table I. The mean age and mean postoperative 
period for the patients at the time of this study were 65 + 
9 years (range 47 to 78 years) and 38 ± 46 months (range 
1 to 154 months), respectively, for the ITA graft group and 
68 + 4 years (range 60 to 75 years) and 48 + 50 months 
(range 1 to 152 months), respectively, for the SVG group. 
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Table I. Patient profiles Table II. Plasma nitrite and nitrate levels' 
ITA SVG p Value* 1TA (n = 24) SVG (n = 16) 
Plasma nitrite level 
Control (10 7 mol/L) 8.85 _+ 4.23 9.18 + 6.60 
Ratio of 4 min after ACH 1.34 ± 0.52"t 1.01 ± 0.24 
Ratio of 6 rain after ACH 1.84 ± 1.07":) i.08 + 0.36 
Total plasma nitrite and 
nitrate level 
Control (10 7 mol/L) 335.0 _+ 179.7 353.1 + 281.0 
Ratio of 4 min after ACH 1.16 _+ 0.51" 0.93 + 0.09 
Ratio of 6 min after ACH 1.08 +_ 0.19 ~s 0.93 + 0.10 
Data presented are mean plus or minus the standard deviation. ACII, 
Acetylcholine. 
*p < 0.05 vs SVGs. 
2 (13%) -] ~p < 0.01 vs SVGs. 
7 (44%) I tp < 0.05 vs control. 
7 (44%) *p < 0.01. 
No. of patients 23 16 
No. of grafts studied 24 16 
Age (yr) 65 -+ 9 68 + 4 0.53 
Female t (4.2%) 2 (12.5%) 0.55 
Coronary risk factors 
Hypertension 11 (46%) 10 (63%) 0.73 
Diabetes mellitus 8 (33%) 7 (44%) 0.66 
Hyperlipidemia 11 (46%) 8 (50%) 0.99 
History of smoking 15 (63%) 13 (81%) 0.26 
Postoperative p riod (mo) 38 _+ 46 48 ± 50 0.45 
Range (mo) 1-154 1-152 
Distal anastomosis 
LAD 15 (63%) 
LCX 8 (33%) 0.001 
RCA 1 (4%) 
LAD, left anterior decending; RCA, right coronac¢ artery. 
*SVG vs ITA. 
There were no significant differences between the two 
groups in age, gender, postoperative p riod, or coronary 
risk factors including hypertension, diabetes mellitus, hy- 
perlipidemia, nd smoking history. All of the grafts were 
used as isolated grafts and all ITAs (19 left ITAs and 5 
right ITAs) were used as in situ grafts. For the grafts 
bypassed to the left circumflex coronary artery (LCX), 
there were also no significant differences between the two 
groups in clinical profiles including age, postoperative 
period, and coronary risk factors. All grafts were anglo- 
graphically patent with good run-off low. 
Study protocol. The study protocol was approved by 
the Institutional Review Committee on Human Research 
of Nara Medical University. Informed consent was ob- 
tained from the patients before the procedure and all the 
studies were completed without complications. Patients 
underwent cardiac atheterization while in a fasting state 
without premedication, after interruption of all vasoactive 
drugs for more than 24 hours. No patients received 
/3-adrenergic receptor blockers within 48 hours before the 
study. After postoperative diagnostic catheterization, a 5F 
Judkins catheter for the right coronary artery was posi- 
tioned at the ostium of the coronary bypass graft, and 
grafts were selectively cannulated to the distal anasto- 
motic site with a 2.7F microcatheter (Tracker-f8 infusion 
catheter, Target Therapeutics) through a guiding cathe- 
ter. Blood in the distal portion of the graft was obtained 
through the microcatheter as a control. Blood was aspi- 
rated through the microcatheter over about 60 to 90 
seconds to avoid hemolysis. Five micrograms or 3 × 10 -s 
tool of acetylcholine solution was then infused into the 
graft through the guiding catheter for 30 seconds. Blood 
samples from the distal portion of the graft were obtained 
in the same manner as for the control, at 4 and 6 minutes 
'after the administration f acetylcholine. Eight minutes 
after the beginning of ace@choline administration, an- 
giography of the grafts and the bypassed coronary arteries 
was performed. Angiograms were not taken in the first 
live patients in the SVG group or in the first six in the ITA 
group, but in the remaining patients angiographic nves- 
tigations were consecutively performed and the diameters 
of grafts and coronary arteries at points about 1 cm 
upstream and downstream from the anastomotic site were 
measured by cine-densitometry. The electrocardiogram 
and arterial pressure were monitored continuously during 
the procedures. Finally, I mg isosorbide dinitrate was 
injected into the graft through the guiding catheter to 
overcome the acetylcholine-induced vasoconstriction. 
Assay of NO concentrations. Blood samples were ob- 
tained through the catheters with the use of disposable 
syringes and centrifuged as soon as possible at 3000 rpm 
for 5 minutes at 4 ° C. Plasma was stored at -80 ° C until 
use. Plasma samples were diluted 1:2 with deionized water 
and filtered through a 0.45 p~m microfilter. Plasma nitrite 
(NO2) and nitrate (NOr)  concentrations were measured 
with an NOx analyzer (Enol0, Eicom, Kyoto, Japan) with 
high-performance liquid chromatography and the Griess 
reaction.9.1o In brief, the samples were first passed 
through a column to separate NOr  from NO2-. Then the 
samples were passed through a second column containing 
copper-coated cadmium to reduce the NOr  to NOr.  
Next the NO 2 was detected by reaction with the Griess 
reagent (0.03 mol/L sulfanilamide plus 0.15 mol/L HC1 
solution containing 1.0 × 10 -3 mol/L N-[1-naphthyl] eth- 
ylenediamine). Absorption was measured at 546 nln with 
use of a spectrophotometer. Thus the separate NO2- and 
NOB " levels could be measured simultaneously. The de- 
tection limit of the assay was 1.0 × 10 -8 mol/L. 
Quantitation of graft and coronai2¢ artery diameters~ 
The diameters of the grafts and grafted coronary arteries 
were calculated by cine-densitometry with a microcom- 
puter analyzing program, Elk Cine-Angio System Cam- 
1000, produced by Nishimoto Sangyo, Osaka, Japan] 1 
Statistical analysis. Measurements arc expressed as 
mean plus or minus standard deviations (percentiles). 
Statistical analysis was performed with the SPSS version 
6.1.3J program (SPSS, Chicago, IlL) on a personal com- 
puter (XL-590/Compaq Computer). The patient profile 
data were analyzed by the X 2 or Mann-Whitney U test, 
and the plasma NO2 and NO 3 concentration data were 
analyzed by the Wilcoxon matched-pairs signed-rank test, 
Mann-Whitney U test, and analysis of variance (Pillai's 
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Fig. 1. Plasma NO 2 concentration after stimulation with 
acetylcholine compared with control level for grafts bypassed 
to the LCX. For grafts to the LCX, plasma NO 2 concen- 
tration after stimulation with acetylcholine compared with 
the control value was significantly higher in ITA grafts than 
in SVGs at 4 minutes (p = 0.04) and at 6 minutes (p = 0.01). 
This response was similar to the result for all study grafts, 
including rafts to other coronary arteries. 
multivariate st). Correlation coelIicients were calculated 
by the method of Pearson. Allp values are two tailed. 
Results 
Plasma NO 2- and NO 3- concentrations. For 40 
grafts in 39 patients who had undergone coronary 
artery bypass grafting, the plasma NO 2 and NO 3 
concentrations in the distal portion of the graft after 
acetylcholine administration are shown in Table II. 
Plasma NO 2 concentration significantly increased 
after acetylcholine infusion in the ITA grafts (at 4 
minutes, p = 0.05; at 6 minutes, p = 0.01), whereas 
there were no significant increases for the SVGs (at 
4 minutes, p = 0.96; at 6 minutes, p = 0.69). The 
response in plasma NO2- levels after stimulation 
with acetylcholine was different between ITA grafts 
and SVGs (at 4 minutes, p = 0.04; 6 minutes, p = 
0.03). The plasma concentration of total NO 2- plus 
NO 3- also responded ifferently to the stimulation 
of acetylcholine between the two groups (at 4 min- 
utes, p = 0.03; 6 minutes, p = 0.01). Significance of 
the difference in plasma NO 2 concentrations be- 
tween the ITA grafts and SVGs was statistically 
borderline by analysis of variance Co = 0.05). A 
significant relation existed in the ratio of plasma 
level of NO 2- to total NO 2 plus NO 3- 6 minutes 
after stimulation with acetylcholine Co = 0.05). 
Because the target coronary arteries of the ITA or 
SVG differed, and the ITA was mainly used for the 
left anterior descending coronary artery and the 
SVG was mainly used for the right coronary artery 
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Fig. 2. The relation between the change in nitrite level 
after acetylcholine infusion and the graft age (period 
between graft implantation and the study). There was no 
significant correlation by regression analysis between the 
change of plasma NO 2 level after acetylcholine infusion 
and the graft age. 
and LCX as shown in Table I, NO 2 responses were 
compared in the bypass grafts for the LCX where 
both the ITA and SVG were used. The plasma NO2 
concentration after stimulation with acetylcholine 
compared with the control value was different be- 
tween the 1TA and SVG (at 4 minutes, p = 0.04; at 
6 minutes, p = 0.01) (Fig. 1). The increase in plasma 
NO 2- levels after stimulation with acetylcholine in 
the ITAs did not reach statistical significance. 
Time between the graft implantation and the 
study ranged from 1 to 154 months for the ITA 
group and from 1 to 152 months for the SVG group. 
However, NO release induced by acetylcholine ad- 
ministration did not differ with regard to the graft 
age. There were no significant correlations or signif- 
icant differences by regression analysis between the 
graft age and ratio of plasma NO 2- after stimulation 
with acetylcholine (Fig. 2). 
Vasomotor response to acetylcholine. Fig. 3 
shows angiograms of an SVG implanted to the LCX 
in a 65-year-old man 115 months after bypass graft- 
ing in the control condition and after intragraft 
infusion of 5/~g acetylcholine. The native coronary 
artery was constricted after acetylcholine adminis- 
tration. Fig. 4 shows angiograms of an ITA graft 
implanted to the left anterior descending artery in a 
52-year-old man 145 months after bypass grafting in 
the control condition and after intragraft infusion of 
5 /,g ace@choline. The native coronary artery was 
dilated after acetylcholine administration. 
Low-dose acetylcho/ine dilated ITA grafts by 
6.3% +_ 11.6% whereas SVGs were reduced by 3.1% 
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Fig. 3. Angiograms of an SVG implanted to the LCX in a 65-year-old man taken 115 months after the 
operation in the control condition (left) and after intragraft infusion of 5 /,g acetylcholine (right). The 
native coronary artery bypassed with an SVG constricted after acetylcholine administration. 
Fig. 4. Angiograms of a left ITA graft implanted to the left anterior descending artery in a 52-year-old 
man taken 145 months after the operation in the control condition (left) and after intragraft infusion of 5 
/xg acetylcholine (right). The native coronary artery bypassed with an ITA graft dilated after acetylcholine 
administration. 
+ 8.9%. Vasomotor responses of the grafts after 
acetylcholine administration were different between 
the ITA grafts and SVGs (p -- 0.02) (Fig. 5). 
Low-dose acetylcholine dilated the coronary ar- 
teries supplied by arterial grafts by 6.3% _+ 16.6% 
whereas coronary arteries upplied by venous grafts 
were reduced by 9.8% _+ 11.8% in diameter. Ace- 
tylcholine-induced vasoconstriction was significantly 
less in the coronary arteries grafted with ITAs than 
in those with SVGs (p = 0.01) (Fig. 6). 
Discussion 
Advantages of the ITA graft over the SVG are 
excellent patency, lower incidence of graft disease in 
the long-term postoperative period, and physiologic 
and anatomic adaptability. 12q~' These advantages 
are apparently a result of the properties of the 
vessel, especially of the endothelium. In organ bath 
experiments, endothelial release of NO was differ- 
ent in ITAs and SVGs in the grafted or ungrafted 
states] ~'-18 In this study, we demonstrated for the 
first time a greater elease of NO in the ITA graft 
than in the SVG in patients 41 _+_ 47.3 months after 
coronary artery bypass grafting. 
NO assay. NO cannot be easily or directly mea- 
sured in biologic tissues or fluids because it is rapidly 
metabolized. Instead, NO concentration is deter- 
mined by measurement of NO 2- and NO 3 concen- 
trations. Determination of total plasma NO 2- plus 
NO 3- concentrations a a measurement of NO con.- 
centration has been previously described and is a 
well established method. ~2'13 Although NO 2 and 
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Fig. 5. Vasomotor esponses of the grafts to acetylcho- 
line (ACH) infusion. Low-dose acetylcholine dilated ITA 
grafts whereas the SVGs were reduced in diameter (ITA 
vs SVG, p = 0.02). 
NO 3 are metabolites of NO, the metabolic rate of 
conversion of NO to NO e- or NO 3- in the blood is 
not presently known. Plasma NO 2 concentration is
very low and previous assays rarely succeeded in the 
measurement of isolated plasma NO a level as a 
measurement of NO production. 14 Our measure- 
ments of separate plasma NO e and NO 3 concen- 
trations were made with instrumentation i corpo- 
rating high-performance liquid chromatography and 
the Griess reaction, which enabled separate valua- 
tion of changes in plasma NO e- and NO 3- concen- 
trations.9, 10 
NO is released bidirectionally by the endotheli- 
urn. 15 Extraluminal NO acts on the underlying vas- 
cular smooth muscle 16 and inhibits smooth muscle 
cell proliferation. Intraluminal NO is released into 
the blood. The results of the concentration measure- 
ments of metabolites in the present study demon- 
strated that the ITA graft actually released NO into 
the blood in response to acetylcholine. The NO- 
releasing response to acetylcholine was also better 
for the ITA grafts to the LCX as compared with that 
of the SVG for the same arterial esions. There seem 
to be no differences in the ability of the graft to 
produce NO regardless of which coronary artery is 
targeted. 
NO plays an important role in many physiologic 
functions. NO inhibits platelet aggregation and pro- 
motes platelet disaggregation. 17 It also inhibits 
platelet and leukocyte adhesions to the endotheli- 
urn, ts protecting the endothelium from injury in- 
duced by superoxide radicals; in addition, intralumi- 
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Fig. 6. Vasomotor esponses of the grafted coronary 
arteries to acetylcholine (ACH) infusion. Acetylcholine- 
induced vasoconstriction was significantly less in the cor- 
onary arteries grafted with ITA grafts than in those 
grafted with SVGs (p = 0.01). 
nally released NO may have a metabolic effect on 
the downstream vascular beds. 19 Therefore ITA 
grafts with NO-releasing endothelium ay have an 
antiatherosclerotic effect on both grafts and grafted 
coronary arteries. 
Vasomotor  response to aeetyleholine. ITAs are 
usually free of atherosclerotic changes 2° and dilate 
in response to local administration of acetylcholine 
as long as the endothelium is functional. 21 The 
results of the NO assay offer an explanation for the 
graft's response to acetylcholine. The endothelial 
release of NO in SVGs was insufficient o reverse 
the direct constrictive ffect of acetylcholine. Here 
we have provided quantitative data comparing the 
response to intragraft administration of low-dose 
acetylcholine of coronary arteries grafted with the 
ITA and SVG. The results are consistent with those 
of a previous angiographic study that examined the 
vasomotor response of grafts and coronary arteries 
grafted with ITAs to the administration of ergono- 
vine or substance p.22, 23 However, high-dose acetyl- 
choline administration can uniformly induce a con- 
strictive response of the coronary artery, and a 
dilative response can be induced by an optimal dose 
of acetylcholine. 24Several reasons for the dilation of 
the coronary arteries bypassed with ITA grafts in 
this study can be considered. First, intraluminally 
released NO from the graft can affect the down- 
stream coronary arteries; second, endothelium-de- 
pendent NO-mediated ilation of the coronary ar- 
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tery occurs in response to acetylchol ine; and third, 
f low-mediated vasodi lat ion after the increased flow 
of the graft occurs in response to acetylchol ine or 
the angiographic  procedures.  A l though we cannot  
exclude other  mechan isms of coronary artery dila- 
t ion such as an invo lvement  of prostacycl in 2s or 
endothe l ium-dependent  hyperpo lar izat ion factor, 2(' 
the results of the NO assay in the present  study offer 
an exp lanat ion  of the coronary artery response by 
the endothe l ium-der ived  NO f rom the grafts. The  
present  angiographic  results may suggest that the 
ITA  graft has a possible metabol ic  effect of protect-  
ing the grafted coronary  arteries from spasm and 
atherosclerosis.  
In  summary ,  the ITA  graft is not  only an excel lent 
condui t  with good long- term patency, but  it also has 
a potent ia l  metabo l ic  effect that protects the graft 
and the grafted coronary arteries f rom spasm and 
atherosclerosis.  This is the first study to demonst ra te  
in human subjects that  in situ ITA  grafts can pro-  
duce more  NO compared  with venous  grafts after 
coronary bypass grafting. Thus coronary artery by- 
pass graft ing with the ITA  may have the salutary 
effect of t ransp lant ing  funct ional  endothel ia l  cells 
into the coronary circulat ion. 
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